HiLung Inc. is pleased to announce its participation as a sponsor and exhibitor at LIVe2026 (Lung In Vitro Event), taking place on October 8–9, 2026, in Archamps, France, near Geneva.
LIVe is an international conference bringing together researchers and industry professionals working on in vitro lung models—laboratory systems that recreate aspects of the human lung and airways. The event provides a forum for sharing advances in these models and their applications in respiratory disease research, drug efficacy testing, and toxicity assessment.
At Booth 6, we will introduce our contract research (CRO) services for pharmaceutical companies targeting a range of difficult-to-treat respiratory diseases, using our human iPSC-derived lung cell and organoid technologies. We will also share highlights from our collaborative research with academic partners and provide information on our cell products, their applications, and supply to Europe and North America.
We welcome opportunities to discuss your research and drug discovery needs and explore potential collaborations. Please visit us at Booth 6.
For more information, please visit the official LIVe2026 website.